Dexcom Continuous Glucose-Monitoring System Nabs FDA Breakthrough Device Designation
Dexcom has been granted FDA Breakthrough Device Designation of its new continuous glucose monitoring system for use in the hospital setting.
Read MoreMar 2, 2022 | FDA Updates, Remote Monitoring | 0 |
Dexcom has been granted FDA Breakthrough Device Designation of its new continuous glucose monitoring system for use in the hospital setting.
Read MoreFeb 16, 2022 | FDA Updates, Remote Monitoring | 0 |
Senseonics announces the approval of its next-generation Eversense E3 CGM System by the U.S. FDA.
Read MoreJan 28, 2022 | Patient Care Equipment | 0 |
Insulet received clearance from the FDA for its Omnipod 5 Automated Insulin Delivery System for individuals with type 1 diabetes.
Read MoreJan 24, 2022 | Company News | 0 |
IBM Watson Health is selling off its healthcare data and analytics assets to a private equity firm, only a month after the unit debuted new artificial intelligence-based imaging technology.
Read MoreDec 16, 2021 | Patient Care Equipment | 0 |
Children’s Hospital Los Angeles developed a new insulin calculator to reduce the need for one-off orders of insulin doses for inpatients with diabetes.
Read More